Genetic Analysis of Autosomal Dominant Polycystic Kidney Disease in Iranian Families: a Combined Sanger and Next-generation Sequencing Study

Overview

Journal J Appl Genet

Publisher Springer

Specialty Genetics

Date 2025 Feb 14

PMID 39951171

Authors

Maryam Rafiee

Masoumeh Razipour

Mohammad Keramatipour

Jamshid Roozbeh

Mona Entezam

Affiliations

Soon will be listed here.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited renal disorder, primarily caused by mutations in the PKD1 and PKD2. Genetic testing is valuable for the diagnosis, prognosis, and clinical management of ADPKD. Next-generation sequencing (NGS) techniques can overcome the limitations of traditional Sanger sequencing for the genetic diagnosis of ADPKD. This study included 18 Iranian ADPKD families. Long-range PCR and Sanger sequencing were used to analyze PKD1 and PKD2. Subsequently, NGS-based gene panel testing and whole-exome sequencing (WES) were also performed in selected families. Pathogenic/likely pathogenic variants were identified in 13/18 families (72.2%), including 9 in PKD1 and 4 in PKD2. Five novel variants were discovered (c.10016C > A, c.2096_2097 + 4del, c.12138 + 5G > C in PKD1; c.2359-8_2373del, c.180_181delGC in PKD2). Additionally, WES revealed a pathogenic PKD1 frameshift deletion (c.11376delG) in one genetically unresolved family, likely missed by initial Sanger sequencing due to allelic dropout. This study expands the mutational spectrum of PKD1/PKD2 with five novel variants. The findings demonstrate the advantages of NGS over conventional Sanger sequencing methods. The genetically unresolved cases suggest the potential involvement of variants within non-coding regions, large copy number variations, or novel genes in ADPKD pathogenesis. Whole-genome sequencing is warranted to investigate these unresolved cases further.

References

Audrezet M, Cornec-Le Gall E, Chen J, Redon S, Quere I, Creff J . Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat. 2012; 33(8):1239-50. DOI: 10.1002/humu.22103. View

Bergmann C, Guay-Woodford L, Harris P, Horie S, Peters D, Torres V . Polycystic kidney disease. Nat Rev Dis Primers. 2018; 4(1):50. PMC: 6592047. DOI: 10.1038/s41572-018-0047-y. View

Besse W, Chang A, Luo J, Triffo W, Moore B, Gulati A . Mutation Carriers Develop Kidney and Liver Cysts. J Am Soc Nephrol. 2019; 30(11):2091-2102. PMC: 6830805. DOI: 10.1681/ASN.2019030298. View

Blais J, Lavoie S, Giroux S, Bussieres J, Lindsay C, Dionne J . Risk of Misdiagnosis Due to Allele Dropout and False-Positive PCR Artifacts in Molecular Diagnostics: Analysis of 30,769 Genotypes. J Mol Diagn. 2015; 17(5):505-14. DOI: 10.1016/j.jmoldx.2015.04.004. View

Bogdanova N, McCluskey M, Sikmann K, Markoff A, Todorov V, Dimitrakov D . Screening the 3' region of the polycystic kidney disease 1 (PKD1) gene in 41 Bulgarian and Australian kindreds reveals a prevalence of protein truncating mutations. Hum Mutat. 2000; 16(2):166-74. DOI: 10.1002/1098-1004(200008)16:2<166::AID-HUMU9>3.0.CO;2-4. View

Bogdanova N, Markoff A, Gerke V, McCluskey M, Horst J, Dworniczak B . Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes. Genomics. 2001; 74(3):333-41. DOI: 10.1006/geno.2001.6568. View

Chung W, Kim H, Hwang Y, Kim S, Ko A, Ro H . PKD2 gene mutation analysis in Korean autosomal dominant polycystic kidney disease patients using two-dimensional gene scanning. Clin Genet. 2006; 70(6):502-8. DOI: 10.1111/j.1399-0004.2006.00721.x. View

Cornec-Le Gall E, Torres V, Harris P . Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases. J Am Soc Nephrol. 2017; 29(1):13-23. PMC: 5748917. DOI: 10.1681/ASN.2017050483. View

Devlin L, Sayer J . Renal ciliopathies. Curr Opin Genet Dev. 2019; 56:49-60. DOI: 10.1016/j.gde.2019.07.005. View

10.

Entezam M, Khatami M, Saddadi F, Ayati M, Roozbeh J, Keramatipour M . PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data. Kidney Res Clin Pract. 2016; 35(2):96-101. PMC: 4919558. DOI: 10.1016/j.krcp.2016.02.003. View

11.

Entezam M, Khatami M, Saddadi F, Ayati M, Roozbeh J, Saghafi H . Genetic analysis of Iranian autosomal dominant polycystic kidney disease: new insight to haplotype analysis. Cell Mol Biol (Noisy-le-grand). 2016; 62(2):15-20. View

12.

Harris P, Rossetti S . Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010; 6(4):197-206. PMC: 4050432. DOI: 10.1038/nrneph.2010.18. View

13.

Hateboer N, Veldhuisen B, Peters D, Breuning M, San-Millan J, Bogdanova N . Location of mutations within the PKD2 gene influences clinical outcome. Kidney Int. 2000; 57(4):1444-51. DOI: 10.1046/j.1523-1755.2000.00989.x. View

14.

Hosseinpour M, Ardalani F, Mohseni M, Beheshtian M, Arzhangi S, Ossareh S . Targeted Next Generation Sequencing Revealed Novel Variants in the and Genes of Iranian Patients with Autosomal Dominant Polycystic Kidney Disease. Arch Iran Med. 2023; 25(9):600-608. PMC: 10685772. DOI: 10.34172/aim.2022.95. View

15.

Hu H, Zhang J, Qiu W, Liang C, Li C, Wei T . Comprehensive strategy improves the genetic diagnosis of different polycystic kidney diseases. J Cell Mol Med. 2021; . PMC: 8256360. DOI: 10.1111/jcmm.16608. View

16.

Hwang Y, Conklin J, Chan W, Roslin N, Liu J, He N . Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2015; 27(6):1861-8. PMC: 4884120. DOI: 10.1681/ASN.2015060648. View

17.

Jin M, Xie Y, Chen Z, Liao Y, Li Z, Hu P . System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease. Sci Rep. 2016; 6:35945. PMC: 5080601. DOI: 10.1038/srep35945. View

18.

Kim H, Park H, Ryu H, Kim H, Lee H, Heo J . Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing. Sci Rep. 2019; 9(1):16952. PMC: 6861305. DOI: 10.1038/s41598-019-52474-1. View

19.

Landsverk M, Douglas G, Tang S, Zhang V, Wang G, Wang J . Diagnostic approaches to apparent homozygosity. Genet Med. 2012; 14(10):877-82. DOI: 10.1038/gim.2012.58. View

20.

Lanktree M, Haghighi A, di Bari I, Song X, Pei Y . Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies. Clin J Am Soc Nephrol. 2020; 16(5):790-799. PMC: 8259493. DOI: 10.2215/CJN.02320220. View